ropivacaine hydrochloride
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
33 FDA-registered drug labelers
Amneal Pharmaceuticals LLC
Anthea Pharma Private Limited
Apex Healthcare Limited
Apothecon Pharmaceuticals Pvt Ltd
Baxter Healthcare Corporation
Benechim
Caplin Steriles Limited
Civica, Inc.
DISHMAN CARBOGEN AMCIS LIMITED
Edmond Pharma Srl
Emcure Pharmaceuticals Limited
Eugia US LLC
Excella GmbH & Co. KG
Fine Chemicals Corporation (PTY) Ltd.
FRESENIUS KABI USA, LLC
Gland Pharma Limited
Glenmark Pharmaceuticals Inc., USA
Haleos Labs Limited
Henry Schein, Inc.
Hikma Pharmaceuticals USA Inc.
Jubilant Biosys limited
Meitheal Pharmaceuticals Inc.
Mylan Institutional LLC
NorthStar Rx LLC
Pharma Source Direct, Inc.
ProPharma Distribution
Sagent Pharmaceuticals
Shandong Anhong Pharmaceutical Co., Ltd.
Siegfried Evionnaz SA
SOLA Pharmaceuticals, LLC
Somerset Therapeutics, LLC
Spectrum Laboratory Products, Inc.
Sportpharm, Inc. dba Sportpharm
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Ropivacaine Hydrochloride
- •Naropin
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Ropivacaine Hydrochloride Injection
03/23/2018Unavailable
current
Ropivacaine Hydrochloride Injection
03/23/2018Available
current
Ropivacaine Hydrochloride Injection
12/22/2020Limited Availability
current
Ropivacaine Hydrochloride Injection
03/27/2018Available
current
Ropivacaine Hydrochloride Injection
12/22/2020Available
Vendor Pricing
$2.44/gAngene Chemical
CountryChina (registered: Hong Kong)
Pack$61.00 / 25 g
Purity98%
Vendors22 available
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
21 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| Combi-Blocks, Inc. | United States | $4.80 | 100 g | 97% |
| Aaron Chemicals LLC | Hong Kong | $5.00 | 1 g | 98% |
| Ambeed, Inc. | United States | $37.80 | 10 g | 97% |
| AA BLOCKS | United States | $38.00 | 1 g | 97% |
| BLD Pharmatech Co., Limited | United States | $47.20 | 5 g | 97% |
| BLD Pharmatech GmbH | Germany | $62.60 | 5 g | 97% |
| BLD Pharmatech Ltd. | China | $62.60 | 5 g | 97% |
| MedChemExpress MCE | Sweden | $110.11 | 1 g | 99.62% |
| Angene International Limited | United States | $129.00 | 1 g | 98% |
| AstaTech (2 weeks) | United States | $166.80 | 5 g | 95% |
| AstaTech, Inc | United States | $167.40 | 5 g | 95% |
| A2B Chem LLC (2 weeks) | United States | $328.00 | 250 mg | 98% |
| A2B Chem LLC | United States | $350.00 | 500 mg | 99.95% |
| AA BLOCKS (2 weeks) | United States | $352.00 | 250 mg | 98% |
| TargetMol Chemicals | China → United States | $452.00 | 500 mg | 99.95% |
| AK Scientific, Inc. | United States | $550.00 | 1 g | 98% |
| Molnova | China | $600.00 | 200 mg | 99% |
| Apexbio Technology LLC | United States | $1360.00 | 50 mg | 99.85% |
| Angene | China → Hong Kong | $4266.67 | 30 mg | 98% |
| Key Organics Ltd. | United Kingdom | $6900.00 | 10 mg | 97% |
| Cayman Europe | Estonia | $295120.00 | 1 mg | 99% |
Chemical Identity
CAS98717-15-8
PubChem CID175804
DTXSIDDTXSID2048379
FormulaC17H27ClN2O
Mol. Weight310.9 g/mol
SMILESCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl
Data Sources
1758042026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ropivacaine hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/ropivacaine hydrochloride.json
CAS 98717-15-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 98717-15-82026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json